ABSTRACT. Numerous studies have been conducted to investigate the association between 2518A/G polymorphisms in the monocyte chemoattractant protein-1 (MCP-1) gene and the risk of tuberculosis (TB). However, the results have been inconsistent and inconclusive. In this study, we performed a meta-analysis to evaluate the association between the MCP-1 -2518A/G polymorphism and TB. The National Center for Biotechnology Information Global Cross Database and Google Scholar database were searched for relative studies. A total of 22 case-control studies that included 7332 cases and 8004 controls for the -2518A/G single-nucleotide polymorphism were identified. The results revealed an association between the MCP-1 -2518A/G polymorphism and human TB susceptibility under a recessive model (GG vs GA+AA), dominant model (GG+GA vs AA), and homozygote comparison (GG vs AA) model for the entire database. For the dominant model, the overall odds ratio was 1.34 (95% confidence interval, 1.10-1.64, P = 0.004). For the recessive model, the overall odds ratio was 1.46 (95% confidence interval, 1.15-1.86, P = 0.002). For the homozygote comparison, the overall odds ratio was 1.67 (95% confidence interval, 1.20-2.32, P = 0.002). In the subgroup analysis by ethnicity, significantly elevated risks were found in Asians and Americans, but not in Africans and Europeans. We also used the Begg and Egger tests to examine publication bias, and no major publication bias was detected. Our results indicate that there is an association between the MCP-1 -2518A/G polymorphism and human TB susceptibility.
INTRODUCTION

Tuberculosis (TB) is an infectious disease caused by the bacillus Mycobacterium tuberculosis
. Although the treatment is inexpensive and has existed for more than 50 years, Mtb remains a global public health problem (Marais et al., 2010) . Approximately 1/3 of the world's population is latently infected and at risk of developing this disease. Approximately 90% of people infected with Mtb never develop TB. It is not known why some individuals exposed to Mtb resist infection more successfully than others. Heritable factors are thought to play an important role in determining the inter-individual variation that leads to higher susceptibility (Singh et al., 2014) . The susceptibility of developing TB disease after exposure is a complex multifactorial trait; disease expression is influenced by complex interactions between the host and pathogen, as well as between genetic and environmental factors (Möller and Hoal, 2010) . Numerous studies have confirmed that various genetic factors affect the susceptibility to TB. An increasing number of studies have been focused on identifying genetic factors causing TB, including the monocyte chemoattractant protein 1 (MCP-1) gene.
MCP-1, also referred as chemokine C-C motif ligand 2 (CCL2), is a member of the small inducible gene family. It plays an essential role in the innate immune response against microbial infection and contributes to adaptive immune defense and long-term immunity (Serbina et al., 2008) . MCP-1/CCL2 shows the highest potential as a chemoattractant and activator for monocytes and plays an important role in the host-pathogen interaction. Increased expression of MCP-1 has been shown to be associated with disease severity of TB (Hasan et al., 2009) . Genetic variations within the MCP-1 gene have also been suggested to be associated with disease susceptibility and manifestation. MCP-1 expression levels are highly variable among individuals, which may contribute to differential susceptibility to the progress of various inflammatory diseases (Frahm et al., 2011) .
Previous studies have identified that polymorphisms in the regulatory regions of the MCP-1 gene were associated with variability in MCP-1 expression levels (Berrahmoune et al., 2007; Pham et al., 2012) . The gene encoding MCP-1 is located in the 17q11.2-q12 chromosomal region; single-nucleotide polymorphisms such as -2518A/G (rs1024611) and -362G/C (rs2857656) have been identified. These polymorphisms may influence MCP-1 secretion, impacting TB susceptibility (Mishra et al., 2012) .
Several studies have investigated the association between these polymorphisms and TB susceptibility; however, the results are inconsistent and inconclusive. Zhang et al. (2012) showed that significantly elevated risks were observed in Asians and Latinos, but not in Africans between the -2518A/G polymorphism in the MCP-1 gene and TB. Another group reported that the CCL2-2518G allele increased the risk of developing TB in Asians and Hispanics (Feng et al., 2012) . Another recent study showed that the G allele of the MCP-1 -2518 polymorphism was a risk factor for TB in Asians and Americans, but not in Africans (Gong et al., 2013) . In this study, we performed a meta-analysis to more comprehensively estimate the association between the -2518A/G polymorphism and human TB susceptibility.
MATERIAL AND METHODS
Study selection
Multiple electronic databases were searched for data collection. For first-round exclusion, studies were searched with National Center of Biotechnology Information Global Cross Database, including PubMed, PMC, Gene, PubChem, etc., using the search terms "tuberculosis", "monocyte chemoattractant protein-1", "MCP-1", "CCL2", and "-2518A/G polymorphism". Search results were limited to studies in English. We excluded books and other literature that were not case-control studies. For second-round selection, we excluded articles that did not investigate the association between MCP-1 -2518A/G polymorphisms and human TB susceptibility. Duplicated studies were eliminated. When data overlapped between studies, we retained those showing the most extensive results.
Statistical methods
To obtain a reasonable statistical conclusion, the association between the MCP-1 -2518A/G polymorphism and TB was evaluated using the odds ratio (OR) derived from different analysis models. Subjects were placed into 4 subgroups based on the region of the case-control study. Subgroup A included 5 studies in Africans. Subgroup B included 4 studies in Americans. Subgroup C included 3 studies in Europeans. Subgroup D included 10 studies in Asians. Three different methods were used: dominant model (GG+GA vs AA), recessive model (GG vs GA+AA), and homozygote comparison (GG vs AA). For each study, the number of subjects with the 3 genotypes in the case and control groups were used as pooled data. When examining studies with large sample sizes, Peto's method (Brockhaus et al., 2014 ) may be misleading. However, the inverse variance method is only effective for continuous data. Another key factor in choosing an analysis model is to test the heterogeneity in the studies. The Mantel-Haenszel (M-H) fixed-effect model should be applied for analyzing datasets without significant heterogeneity and the DerSimonian and Laird random-effects model should be applied for datasets showing obvious heterogeneity. In our analysis, the heterogeneity between studies was tested using the I 2 index, using an equation in which Q was the statistical data and df was the degrees of freedom. A higher value of I 2 indicated more significant heterogeneity. Values of I 2 = 25, 50, and 75% represented low, medium, and high heterogeneity, respectively. When I 2 ≤ 25, 50, and 75%, there was no significant heterogeneity among pooled data. In this meta-analysis, 22 studies were included in the final analysis for -2518A/G. For each analysis, we first used the M-H fixed-effect model to test the heterogeneity, and then used different models based on these results. ORs were calculated for each model with 95% confidence intervals (95%CIs). Available polymorphism data were analyzed using STATA 12 (StataCorp, College Station, TX, USA). Forest plots were generated to summarize the results. To evaluate publication bias, Begg's funnel plots were generated based on the analysis results and database size. Funnel plots showing higher asymmetry indicated higher publication bias. In addition, the Egger test was also performed for publication bias evaluation.
RESULTS
Data collection
A total of 149 results were identified in the selected electronic databases. We excluded books and other studies that were not case-control studies, resulting in 67 articles. After excluding the articles that did not investigate the association between MCP-1 -2518A/G polymorphisms and human TB susceptibility, 24 articles remained. Duplicated studies were eliminated and only those with the most extensive results were retained. A total of 18 articles, including 22 case-control studies, were included in the final meta-analysis. The data collection flow chart is shown in Figure 1 . 
Characteristics of studies included
In this meta-analysis, we included 22 studies divided into 4 subgroups. The African group included 5 studies [Buijtels et al., 2008; Möller et al., 2009; Thye et al., 2009; Velez Edwards et al., 2012 (2 case-control (Ben-Selma et al., 2011; Hussain et al., 2011; Arji et al., 2012) . The Asian group included 10 studies (Flores-Villanueva et al., 2005; Chu et al., 2007; Alagarasu et al., 2009; Xu et al., 2009; Yang et al., 2009; Feng et al., 2011; Naderi et al., 2011; Mishra et al., 2012; Zhang et al., 2012; Singh et al., 2014) . All studies analyzed the association between MCP-1 -2518A/G polymorphisms and human TB susceptibility. The characteristics of all studies are shown in Table 1 
Analysis of MCP-1 -2518A/G polymorphism and TB susceptibility
First, we performed the analysis for the entire data set. Three analysis methods (dominant, recessive, and homozygote comparison) were applied. Based on the heterogeneity observed in the data, the DerSimonian and Laird random-effect model was applied with all 3 analysis methods. Final results are shown in Table 2 . Corresponding forest plots and funnel plots for each model are shown in Figures 2 and 3 . For the dominant model, the overall OR was 1.34 (95%CI = 1.10-1.64, P = 0.004), and minor publication bias was observed. For the recessive model, the overall OR was 1.46 (95%CI = 1.15-1.86, P = 0.002), and no significant publication bias was observed. For the homozygote comparison, the overall OR was 1.67 (95%CI = 1.20-2.32, P = 0.002), and no significant publication bias was observed.
Similarly, for subgroup analysis, the M-H fixed-effects model was applied for each subgroup dataset using 3 different analysis models (dominant, recessive, and homozygote) to examine heterogeneity. Based on the results, we selected different methods (M-H fixed-effects model or DerSimonian and Laird random-effects model) for analysis. We then continued with the final analysis to derive the OR as well as its P value. In the subgroup analysis by ethnicity, a significantly increased risk of TB because of the MCP-1 -2518A/G polymorphism was observed among the American population (dominant model: OR = 1.694, 95%CI = 1.019- 
DISCUSSION
Our results revealed an association between the MCP-1 -2518A/G polymorphism and human TB susceptibility using all 3 analysis models for all data. The studies included contained data from African, American, Europeans, and Asian populations. Because the same nucleotide polymorphism can function differently in different genetic backgrounds, the results for these 4 ethnicities should be interpreted with caution. Therefore, we further investigated the susceptibility in 4 population subgroups. After stratification by ethnicity, significantly elevated risks were observed in Americans and Asians, but not in Africans and Europeans. This may be because of the relatively small size of the database and because the results were not very uniform. This may also be because of genetic differences among the populations.
In our meta-analysis of the MCP-1 -2518A/G polymorphism, significant heterogeneity was found in the overall effect. Several factors may have affected this heterogeneity. First, the populations had different genetic backgrounds (Tian et al., 2011) . Second, environmental factors in different case-control studies were not investigated, which may have influenced TB susceptibility. Third, the cases and controls included were not very homogenous in the analysis.
There were 3 previous meta-analyses that evaluated the association between the MCP-1 -2518A/G polymorphism and TB susceptibility (Feng et al., 2011; Zhang et al., 2012; Gong et al., 2013) . Compared with these reports, ours revealed some new insights. First, our dataset was much more comprehensive, and additional recently published studies were included when estimating the risk associated with the MCP-1 -2518A/G polymorphism. Second, only high-quality studies were included in our analysis; we provided a more precise overview of the studies included through strict study selection and data extraction. Moreover, we used 3 different genetic models to analyze the association in subgroups and in the entire population.
There were several limitations to this study. First, because not all of the original data from each study were available, we could not analyze the effect of the polymorphism on various types of TB (pulmonary TB and extra-pulmonary TB). Second, genetic heterogeneity among different populations emphasizes the need to interpret the results with caution. Despite these limitations, our meta-analysis results suggest that the MCP-1 -2518A/G polymorphism is significantly associated with an increased risk of TB. Future well-designed studies with a larger sample size and including different ethnicities are needed.
